Australian biotechnology company Cellmid has entered into an option agreement with Japanese company Fujikura Kasei. Under the option to license agreement, Cellmid will supply its proprietary anti-midkine diagnostic antibodies for ...
Tags: Cellmid, Fujikura Kasei, anti-midkine diagnostic antibodies
The US Patent and Trademark Office (USPTO) has granted a new patent to MorphoSys' antibody platform Ylanthia. The new patent (US 8,367,586), which the company claims is the first for its antibody platform, covers the composition of ...
Tags: MorphoSys, antibody, antibody platform
US-based biotechnology company Seattle Genetics has announced that it has gained the Health Canada's Notice of Compliance with conditions (NOC/c) for marketing its ADCETRIS ((Brentuximab Vedotin)) drug used in treating two lymphoma ...
Tags: Seattle Genetics, ADCETRIS drug, Health Canada's Notice of Compliance
The Amgen pharmaceutical of The United States invested two hundred million to build a new plant in Singapore, It is reported that the new plant will be located in Singapore Tuas Biomedical Park. The Amgen pharmaceutical company said that ...
One Lambda, which is now part of Thermo Fisher Scientific, has gained regulatory approvals from the US Food and Drug Administration and Ministry of Health Canada for its HLA Fusion Software version 3.0. HLA Fusion Software version 3.0, ...
Tags: HLA Fusion Software, Drug, Medicine
The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for Novartis Ilaris for use in acute gouty arthritis patients who are not suitable for current treatments. The only ...
Tags: Medicinal Products, therapies, treatments
Lab M has launched Captivate O104, an important new addition to its established range of immunomagnetic separation (IMS) products. Captivate O104 is designed to meet the increasing need to rapidly test fresh sprouted seeds for the presence ...
Tags: Lab M, Captivate O104, IMS
Bicycle Therapeutics,had secured a tranched equity financing of £3.75 million to invest in selection of drug candidates using its bicyclic peptide technology platform. Current investors, Atlas Venture, Novartis Venture Fund, SR One ...
Tags: Bicycle, drug discovery funding, pharma, healthcare
Biogen Idec and Elan are seeking approvals from the US Food and Drug Administration (FDA) and European Medicines Agency (EMA) for first-line use of Tysabri (natalizumab) in anti-JCV antibody negative patients with multiple sclerosis (MS). ...
MRC Technology, a technology transfer charity and company, announced at the end of last year a pound 577,000 funding award from the Biomedical Catalyst. The award has been granted to MRC Technology to fund research into the role of ...
Life science research and clinical diagnostic products manufacturer Bio-Rad Laboratories has acquired AbD Serotec, a division of MorphoSys. Under the transaction, Bio-Rad paid euro 53m in cash to AbD Serotec, which offers over 15,000 ...
Tags: clinical diagnostic products, Bio-Rad Laboratories, AbD Serotec
Germany based MorphoSys has closed the transaction of selling its AbD Serotec segment to Bio-Rad. Transfer of all assets and liabilities of MorphoSys'research and diagnostic antibody segment,the AbD Serotec,in addition to all shares of ...
Tags: shares, AbD Serotec, Bio-Rad, divestment
Therapeutic antibody company AIMM Therapeutics has collaborated with Italy-based Cosmo Pharmaceuticals to develop oral diagnostic and therapeutic antibodies for gastrointestinal diseases, including colon carcinoma. As part of the ...
Amgen has licensed ImmunoGen's Targeted Antibody Payload (TAP) technology to develop anticancer therapeutics for an undisclosed amount. ImmunoGen president and CEO Daniel Junius said major healthcare companies are interested in developing ...
Tags: anticancer therapeutics, healthcare companies, healthcare, ImmunoGen
Lonza has received a contract from Intellect Neurosciences to develop and manufacture the antibody drug conjugate, Conjumab-A. Under the contract, Lonza will supply the preclinical study material for the drug optimization and drug ...
Tags: Lonza, antibody drug, Neurosciences, antibody drug conjugate